Multiple Sclerosis Resource Centre
  • Home
  • World MS Day (Green Day)
  • About MS
  • MSRC Services
  • Get Involved
  • MS Research News
  • MSRC Groups
  • Useful Resources
  • Advertising
  • MSRC Guest Book
  • Best Bet Diet Group
  • E-Newsletter
  • Contact Us
  • Investor in People
    You are here : Home » MS Research News » Drugs » Genetically Modified Drugs And Components

    Genetically Modified Drugs And Components

    A A A
    [Print this page]

    Share |


    Roslin's chicken eggs could help save lives
    Midlothinan scientists have hit the headlines again after developing chickens capable of laying potentially life-saving eggs.

    Researchers at Roslin Institute, which created the world famous Dolly the Sheep, have produced five generations of the genetically-modified birds.

    The birds' egg whites are packed with proteins needed to make large quantities of drugs, which could be used to treat multiple sclerosis and skin cancer.

    The work, being led by Roslin Institute's Dr Helen Sang, is a joint Avian Transgenic Technology venture with biotechnology firms Viragen, based at Midlothian's Pentlands Science Park, and Oxford BioMedica.

    Roslin Institute director Professor Harry Griffin explained that Dr Sang's research had efficiently created transgenic chickens and been able to add a human gene and protein so they would only appear in the egg white and nowhere else in the bird.

    "The aim of this project is to use chickens as an inexpensive way of producing expensive medical proteins. A chicken has been engineered to produce two special human proteins, B-1a interferon, which is already in use for the treatment of multiple sclerosis, and a second protein, a mini antibody, which is being developed as a potential treatment for human skin cancer," said the professor.

    "The idea is that we will be able, in the future, to have relatively small flocks producing these proteins but that may not necessarily be in Midlothian."

    Professor Griffin said it would be five or more years before treatments could be available from this new technology. He added that it could be developed to treat other diseases, which required large quantities of human protein.

    Source: Midlothian Today All rights reserved © 2007 Johnston Press Digital Publishing.(17/01/07)

    © Multiple Sclerosis Resource Centre

    Related Items
    Aimspro (Goats Serum)
    Ampyra (Fampyra)
    ATX-MS-1467
    Azathioprine
    BG-12
    BHT-3009
    Cannabis And Cannabinoid Research
    CHR-1103
    Cladribine
    Cyclophosphamide
    Cyrevia
    Disease Modifying Drugs
    Further Possible MS Drugs and Treatments
    Gilenya® (fingolimod)
    Laquinimod
    Lemtrada (alemtuzumab)
    Low Dose Naltrexone - Latest News
    Masitinib
    MBP8298
    Minocycline
    Mitoxantrone and Copaxone Combination Therapy
    MN-166 (Ibudilast)
    Modafinil
    NeuroVax
    Novantrone (Mitoxantrone)
    PEGylated interferon beta
    Possible Drugs For The Treatment Of MS Symptoms
    Prokarin
    Pycnogenol
    Rituximab (Rituxan)
    RPI-78M
    RTL-1000
    Sativex®
    Statins
    Teriflunomide (Aubagio™)
    Tovaxin
    Trimesta (Oral Estriol)
    Viagra (sildenafil)
    Zenapax (daclizumab)


    Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us.